Metraipolis › archive › dc_bcf7281d3dc7

Anti-Amyloid Therapies for Alzheimer's Disease: Progress, Pitfalls, and the Path Ahead — Europe PMC PMID:41096797

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41096797
DOI
10.3390/ijms26199529
License (as archived)
solo-consultazione
Archived
2026-11-09T16:53:42.715Z
SHA-256 of the archived text
264d3653e69ded71684f12b74577e19d3ed560712a22d490df602d65a6ec7fba
Stable URL of this page
https://metraipolis.com/documento/dc_bcf7281d3dc7

How to cite

Anti-Amyloid Therapies for Alzheimer's Disease: Progress, Pitfalls, and the Path Ahead — Europe PMC PMID:41096797 — Europe PMC (en), https://europepmc.org/article/MED/41096797 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bcf7281d3dc7 (Metraipolis archive dc_bcf7281d3dc7, sha256 264d3653e69ded71684f12b74577e19d3ed560712a22d490df602d65a6ec7fba)
BibTeX
@misc{dcbcf7281d3dc7,
  title = {Anti-Amyloid Therapies for Alzheimer's Disease: Progress, Pitfalls, and the Path Ahead — Europe PMC PMID:41096797},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41096797},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bcf7281d3dc7; sha256 264d3653e69ded71684f12b74577e19d3ed560712a22d490df602d65a6ec7fba},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41096797. Agents can read the archived copy with the MCP tool read_document.